
Fortis Healthcare Ltd. (FORTIS): Fortis Healthcare Share Price falls near 52-week low after 4.77% drop
Updated: 30 Sept 2026 • 11:09 am
Posted by:

Fortis Healthcare Share Price is under pressure today, with the stock at Rs 779.95 after a 4.77% decline, placing it close to its 52-week low while the market capitalisation stands at Rs 62,782.32 crore. The latest move makes Fortis Healthcare Share Price a clear stock-market focus for traders tracking Fortis Healthcare Share Price Today, because the session combined a weak close, a lower price band and a fresh look at valuation, momentum and sector positioning. The supplied data confirms the price event, but it does not establish a company-specific catalyst. For readers searching Fortis Healthcare Stock News, the key question is whether the weakness is isolated to price action or also reflected in technical and fundamental indicators. Univest analysis shows the stock now sits below its short-term trend markers, which keeps Fortis Healthcare Share Price in the near-term attention zone.
Fortis Healthcare Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 779.95 |
| Previous Close | Rs 819 |
| Today's Move | Rs -39.05 (-4.77%) |
| Open | Rs 814.6 |
| High | Rs 822.1 |
| Low | Rs 772.7 |
| Market Capitalisation | Rs 62,782.32 crore |
Fortis Healthcare Ltd. (FORTIS) traded at Rs 779.95 versus the previous close of Rs 819, a fall of 4.77%. The stock opened at Rs 814.6, reached a high of Rs 822.1, touched a low of Rs 772.7.
Fortis Healthcare Share Price Today shows a decisive intraday drop from the previous close of Rs 819 to Rs 779.95, a fall of Rs 39.05 or 4.77%. The stock opened at Rs 814.6, touched a high of Rs 822.1 and a low of Rs 772.7, which means the session stayed pressured after the open and finished close to the lower end of the day range. That price behaviour explains why Fortis Healthcare Share Price is being tracked closely in Stock Market Today screens and among Stocks in News. With market capitalisation at Rs 62,782.32 crore, Fortis remains a large healthcare franchise even as Selling Pressure weighs on Price Action. On a near-52-week-low basis, the share is trading within a narrow band of that yearly low zone, so Fortis Healthcare Share Price remains relevant for investors watching support, trend quality and Fortis Healthcare Share Price Update developments. The next check is whether the current level can stabilise above recent lows and improve the daily structure.
Fortis Healthcare Ltd. (FORTIS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 62,782.32 crore |
| P/E Ratio | 59.01x |
| P/B Ratio | 6.08x |
| ROE | 11.32% |
| ROCE | 14.07% |
| EPS | Rs 13.88 |
| Book Value Per Share | Rs 134.61 |
| Dividend Yield | 0.12% |
Fortis Healthcare Ltd. (FORTIS) fundamental metrics show P/E 59.01x, P/B 6.08x, ROE 11.32%, ROCE 14.07%. These figures provide context only and are not a buy or sell signal.
Fortis Healthcare Ltd. has a market capitalisation of Rs 62782.32 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 59.01x, P/B at 6.08x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.32% and ROCE of 14.07%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 13.88, book value per share of Rs 134.61, dividend yield of 0.12%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 42.95x, median ROE of 13.01%, median ROCE of 15.84%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 59.01x |
| Benchmark Median P/E | 42.95x |
| Benchmark Average P/E | 89.72x |
| Benchmark P/E Range | 0x to 1,572.9x |
| Company P/B Ratio | 6.08x |
| Benchmark Median P/B | 3.76x |
| Company ROE | 11.32% |
| Benchmark Median ROE | 13.01% |
| Company ROCE | 14.07% |
| Benchmark Median ROCE | 15.84% |
| Company Market Capitalisation | Rs 62,782.32 crore |
| Benchmark Median Market Cap | Rs 533.06 crore |
Fortis Healthcare Ltd. (FORTIS) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
Fortis Healthcare Ltd. (FORTIS) has a P/E ratio of 59.01x, which is above the benchmark median of 42.95x, a difference of +37.39%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Fortis Healthcare Ltd. (FORTIS) has a ROE of 11.32%, which is below the benchmark median of 13.01%, a difference of -12.99%. Fortis Healthcare Ltd. (FORTIS) has a ROCE of 14.07%, which is below the benchmark median of 15.84%, a difference of -11.17%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Aster DM Healthcare Ltd. | ASTERDM | 65,183.66 | 201.12 | 15.15 | 13.07 | 16.22 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 94,970.23 | 110.4 | 5.4 | 12.95 | 13.93 |
| Max Healthcare Institute Ltd. | MAXHEALTH | 97,418.62 | 65.73 | 8.76 | 14.53 | 14.97 |
| Global Health Ltd. | MEDANTA | 38,551.27 | 68.43 | 9.26 | 15.12 | 19.38 |
| Narayana Hrudayalaya Ltd. | NH | 37,159.95 | 45.15 | 7.76 | 19.86 | 16.2 |
Fortis Healthcare Ltd. (FORTIS) has a P/E ratio of 59.01x compared with the displayed peer median of 68.43x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.32% compares with a peer median of 14.53% across the companies shown in the table. ROCE stood at 14.07% versus the displayed peer median of 16.2%, providing a capital-efficiency comparison. Fortis Healthcare Ltd. (FORTIS) has a market capitalisation of Rs 62,782.32 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Fortis Healthcare
- Fortis Healthcare Share Price is trading near its 52-week low, so short-term price structure is under close observation.
- Fortis Healthcare Share Price Today remains below the 50 DMA and 200 DMA, which keeps the technical setup weak.
- Fortis Healthcare Fundamental Analysis shows a large market cap, revenue growth and a premium valuation profile.
- Fortis Healthcare Share News is being compared with peers that show stronger return ratios or higher multiples.
- Healthcare sector benchmarks show the stock trading above median P/E and P/B, while ROE and ROCE sit below the industry median.
About Fortis Healthcare
Fortis Healthcare Ltd. operates in the Hospital & Healthcare Services industry within the Healthcare sector. The company is known for providing hospital-based medical care and related services across its healthcare platform. Fortis Healthcare Stock News often attracts attention because the business sits in a defensive sector, yet its share price can still move sharply when sentiment changes. The financial track record supplied here shows rising revenue and a stable profit base over the recent quarters, which helps explain why Univest tracks Fortis Healthcare Share Price as both a market event and a business-quality story. The company’s EPS of Rs 13.88, book value of Rs 134.61 and dividend yield of 0.12% add extra context for investors reviewing Fortis Healthcare Company News alongside valuation and sector comparison. In short, the business is a large healthcare operator with meaningful scale, established market standing and a valuation that remains closely watched by the market.
Track Fortis Healthcare Share Price on Univest
Use Fortis Healthcare Ltd. (FORTIS) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Track Fortis Healthcare Share Price on Univest for live price updates, technical indicators, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest brings Fortis Healthcare Share Price Today into one view so investors can follow price action, valuation context and sector comparison in a simple format.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Fortis Healthcare Share Price falling today?
Ans. Fortis Healthcare Share Price fell 4.77% to Rs 779.95 after opening at Rs 814.6 and trading between Rs 772.7 and Rs 822.1. The supplied data confirms the price move, but it does not establish a company-specific catalyst.
Is Fortis Healthcare Share Price near its 52-week low?
Ans. Yes. Fortis Healthcare Share Price is trading close to its 52-week low and 52-week trough zone, which is why the stock is drawing attention from traders tracking Stocks at 52 Week Low and Price Action.
Is Fortis Healthcare Share Price expensive on valuation?
Ans. Fortis Healthcare Share Price trades at a P/E of 59.01 and a P/B of 6.08. In the same-industry benchmark, both metrics are above the median, so the stock remains valued above the industry norm.
What do ROE and ROCE show for Fortis Healthcare?
Ans. Fortis Healthcare reports ROE of 11.32% and ROCE of 14.07%. These figures show moderate return generation, but they sit below the industry medians supplied for the healthcare peer set. ROE stands at 11.32%.
How strong is Fortis Healthcare Share Price against peers?
Ans. Fortis Healthcare Share Price sits between larger peers such as Max Healthcare and Apollo Hospitals and smaller names like Global Health and Narayana Hrudayalaya. Its valuation is high, while return ratios are mid-range.
What should investors monitor next in Fortis Healthcare Share Price?
Ans. Investors should monitor whether Fortis Healthcare Share Price can stabilise after the latest fall, how it behaves around the yearly low zone, and whether valuation remains supported by revenue and profit trends.
Recent Articles

LENSKART SOLUTIONS LTD (LENSKART) Share Price Rise Streak Extends to Second Straight Session
30 September 2026

Jubilant Ingrevia (JUBLINGREA) Share Price rises 5.16% today as stock trades at Rs 673
30 September 2026

Globus Spirits (GLOBUSSPR) Share Price hits fresh 52-week low as stock trades at Rs 798.90
30 September 2026

Schloss Bangalore Ltd. (THELEELA) Share Price rises 6.16% as THELEELA trades at Rs 566.9
30 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
LENSKART SOLUTIONS LTD (LENSKART) Share Price Rise Streak Extends to Second Straight Session
Jubilant Ingrevia (JUBLINGREA) Share Price rises 5.16% today as stock trades at Rs 673
Globus Spirits (GLOBUSSPR) Share Price hits fresh 52-week low as stock trades at Rs 798.90
Schloss Bangalore Ltd. (THELEELA) Share Price rises 6.16% as THELEELA trades at Rs 566.9
SJVN (SJVN) 52 Week Low Streak: second straight session decline
Popular this week
EPW INDIA LIMITED (EPWINDIA) Share Price rises 8.7% to Rs 250

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





